BioSpace News Archive

The global pharma & healthcare market report points out the key trends and developments taking place in this business space in the ongoing COVID-19 times.

The global pharma & healthcare market report points out the key trends and developments taking place in this business space in the ongoing COVID-19 times.

NeuroSigma, Inc., a bioelectronic medical device company, today announced FDA Breakthrough Device Designation for its Monarch eTNS System® for “adjunctive use for reducing the frequency of seizures in individuals 18 years of age or older diagnosed with epilepsy characterized by partial-onset seizures, with or without secondary generalization, that are refractory to two or more antiepileptic medications.”

BioXcel Therapeutics, Inc. (Nasdaq: BTAI), today announced the publication of results from its pivotal Phase 3 SERENITY II trial of BXCL501 (sublingual dexmedetomidine) for the acute treatment of agitation associated with bipolar disorder in the Journal of the American Medical Association(JAMA).

There’s been a steady rise in government endeavor to promote essential awareness about the adverse effects of unwanted pregnancies and population growth.

AB Science SA (Euronext - FR0010557264 - AB) today announced publication of results from its positive pivotal phase 3 trial of masitinib in progressive forms of multiple sclerosis in the peer-reviewed journal Neurology® Neuroimmunology & Neuroinflammation, an official journal of the American Academy of Neurology.

The global Cerebrospinal Fluid Management Market is forecasted to be worth USD 2.00 Billion by 2027, according to a current analysis by Emergen Research.

The global Electrosurgical Devices Market will be worth USD 7.62 Billion by 2027, according to a current analysis by Emergen Research.

The global cold plasma market is projected to be valued at USD 4,517.8 Million by 2027, according to a current analysis by Emergen Research.

The increasing penetration of smartphones and the emergence of resilient internet connectivity solutions in developing nations is boosting market expansion.